| CGTX Stock | | | USD 0.45 0.03 7.14% |
Cognition Therapeutics financial indicator trend analysis is way more than just evaluating Cognition Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cognition Therapeutics is a good investment. Please check the relationship between Cognition Therapeutics Retained Earnings and its Accounts Payable accounts. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Cognition Stock please use our
How to Invest in Cognition Therapeutics guide.
Retained Earnings vs Accounts Payable
Retained Earnings vs Accounts Payable Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Cognition Therapeutics Retained Earnings account and
Accounts Payable. At this time, the significance of the direction appears to have pay attention.
The correlation between Cognition Therapeutics' Retained Earnings and Accounts Payable is -0.8. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Cognition Therapeutics, assuming nothing else is changed. The correlation between historical values of Cognition Therapeutics' Retained Earnings and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Cognition Therapeutics are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Retained Earnings i.e., Cognition Therapeutics' Retained Earnings and Accounts Payable go up and down completely randomly.
Correlation Coefficient | -0.8 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Accounts Payable
An accounting item on the balance sheet that represents Cognition Therapeutics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Cognition Therapeutics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Cognition Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cognition Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in estimate.
For more information on how to buy Cognition Stock please use our
How to Invest in Cognition Therapeutics guide.
Issuance Of Capital Stock is likely to rise to about 11.5
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 9.8
M in 2024.
Cognition Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Cognition Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Cognition Stock Analysis
When running Cognition Therapeutics' price analysis, check to
measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.